Item 7.01 Regulation FD Disclosure.

On January 9, 2023, Decibel Therapeutics, Inc. (the "Company") made available an updated corporate presentation, which it plans to use for meetings with investors and analysts at the Annual J.P. Morgan Healthcare Conference in San Francisco, California, and is attached as Exhibit 99.1 hereto. The presentation is also available through the "Investors" section of the Company's website (http://www.decibeltx.com) under "Events and Presentations". The information contained in, or that can be accessed through, the Company's website is not a part of this filing.

The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit No.       Description

99.1                Corporate presentation dated January 2023.

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses